Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

NHS Scotland PET CT Isolators

  • First published: 02 July 2019
  • Last modified: 02 July 2019
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
Published by:
The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Authority ID:
AA20671
Publication date:
02 July 2019
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

NHS National Services Scotland (NSS) have commissioned the implementation of gallium-68 PET/CT imaging services in 4 health boards across Scotland: Lothian; Grampian; Tayside and Greater Glasgow and Clyde (GGC). Gallium-68 (Ga68) is now the gold standard for the detection and localisation of neuroendocrine tumours (somatostatin receptor imaging) and is an emerging prospect for improved prostate cancer imaging.

The location of the Ga68 manufacturing and dispensing service in each health board will differ, depending on local requirements, however each health board will be required to dispense Ga68 radiopharmaceuticals in an appropriately shielded clean air device, such as an isolator, hot cell or biological safety cabinet that meets the requirements of a Grade A environment, as stipulated in the European Commission’s Guidance for Good Manufacturing Practice (EU GMP), Annex 1.

Gallium-68 for use in the preparation of Ga68-radiopharmaceuticals can be generated from a Ga68 generator or a cyclotron, with each Health Board having a preference for how they will generate Ga68 to provide the service to their patients.

NHS Scotland has commissioned the procurement of PET isolators for the dispensing of Ga68-radiopharmaceuticals in up to 4 centres across Scotland. The isolator must provide sufficient radiation protection to ensure the radiation dose to operators is as low as reasonably practicable (ALARP), while providing a sterile environment to protect the patient against microbial contamination in their dose.

This procurement exercise was to procure two (2) isolators, suitable for handling Ga68, and other PET isotopes, which will be located, one (1) each, within Lothian Heath Board (at Royal Infirmary of Edinburgh, Edinburgh) and Tayside Health Board (at Ninewells Hospital, Dundee).

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

The Common Services Agency (more commonly known as NHS National Services Scotland) (‘NSS’)

Gyle Square (NSS Head Office), 1 South Gyle Crescent

Edinburgh

EH12 9EB

UK

Contact person: Alan Summers

Telephone: +44 1312756511

E-mail: alan.summers@nhs.net

NUTS: UKM

Internet address(es)

Main address: http://www.nhsscotlandprocurement.scot.nhs.uk/

Address of the buyer profile: https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883

I.1) Name and addresses

NHS Lothian

Procurement Headquarters, Lothian Health Board Waverley Gate 2-4 Waterloo Place

Edinburgh

EH1 3EG

UK

Contact person: Alan Summers

Telephone: +44 1312756511

E-mail: alan.summers@nhs.net

NUTS: UKM

Internet address(es)

Main address: http://www.nhslothian.scot.nhs.uk/

Address of the buyer profile: https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA00326

I.1) Name and addresses

NHS Tayside

Ninewells Hospital

Dundee

DD1 9SY

UK

Contact person: Alan Summers

Telephone: +44 1312756511

E-mail: alan.summers@nhs.net

NUTS: UKM

Internet address(es)

Main address: http://www.nhstayside.scot.nhs.uk

Address of the buyer profile: https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA00154

I.2) Joint procurement

The contract involves joint procurement

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

NHS Scotland PET CT Isolators

Reference number: NP194/19

II.1.2) Main CPV code

33100000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

NHS National Services Scotland (NSS) have commissioned the implementation of gallium-68 PET/CT imaging services in 4 health boards across Scotland: Lothian; Grampian; Tayside and Greater Glasgow and Clyde (GGC). This procurement was to procure two (2) Gallium-68 Isolators, to be located, one (1) each, within Lothian Health Board and Tayside Health Board.

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 190 126.00  GBP

II.2) Description

II.2.2) Additional CPV code(s)

33124000

II.2.3) Place of performance

NUTS code:

UKM75

UKM71


Main site or place of performance:

One Gallium-68 Isolator will be installed in each of:

Royal Infirmary of Edinburgh, Edinburgh, and

Ninewells Hospital, Dundee

II.2.4) Description of the procurement

NHS National Services Scotland (NSS) have commissioned the implementation of gallium-68 PET/CT imaging services in 4 health boards across Scotland: Lothian; Grampian; Tayside and Greater Glasgow and Clyde (GGC). Gallium-68 (Ga68) is now the gold standard for the detection and localisation of neuroendocrine tumours (somatostatin receptor imaging) and is an emerging prospect for improved prostate cancer imaging.

The location of the Ga68 manufacturing and dispensing service in each health board will differ, depending on local requirements, however each health board will be required to dispense Ga68 radiopharmaceuticals in an appropriately shielded clean air device, such as an isolator, hot cell or biological safety cabinet that meets the requirements of a Grade A environment, as stipulated in the European Commission’s Guidance for Good Manufacturing Practice (EU GMP), Annex 1.

Gallium-68 for use in the preparation of Ga68-radiopharmaceuticals can be generated from a Ga68 generator or a cyclotron, with each Health Board having a preference for how they will generate Ga68 to provide the service to their patients.

NHS Scotland has commissioned the procurement of PET isolators for the dispensing of Ga68-radiopharmaceuticals in up to 4 centres across Scotland. The isolator must provide sufficient radiation protection to ensure the radiation dose to operators is as low as reasonably practicable (ALARP), while providing a sterile environment to protect the patient against microbial contamination in their dose.

This procurement exercise was to procure two (2) isolators, suitable for handling Ga68, and other PET isotopes, which will be located, one (1) each, within Lothian Heath Board (at Royal Infirmary of Edinburgh, Edinburgh) and Tayside Health Board (at Ninewells Hospital, Dundee).

II.2.5) Award criteria

Quality criterion: Technical / Weighting: 60

Cost criterion: Cost / Weighting: 40

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2019/S 060-138288

Section V: Award of contract

Contract No: NP194/19

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

07/06/2019

V.2.2) Information about tenders

Number of tenders received: 4

Number of tenders received from SMEs: 3

Number of tenders received from tenderers from EU Member States: 3

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 4

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Amercare Ltd

Unit L, Howland Road Business Park, Howland Road

Thame

OX9 3GQ

UK

Telephone: +44 1844261244

NUTS: UKJ14

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 190 126.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information

While the Authority was conducting this procurement exercise, the intention upon award of contract was that both Lothian Health Board and Tayside Health Board will place a purchase order with the successful contractor for the supply of their specific requirements.

The estimated contract value entered at Section II.1.5 was based on the supply, installation and warranty under the contract.

(SC Ref:589258)

VI.4) Procedures for review

VI.4.1) Review body

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

Gyle Square (NSS Head Office), 1 South Gyle Crescent

Edinburgh

EH12 9EB

UK

Telephone: +44 1698794540

E-mail: paul.hornby@nhs.net

Internet address(es)

URL: http://www.nhsscotlandprocurement.scot.nhs.uk/

VI.4.3) Review procedure

Precise information on deadline(s) for review procedures:

The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.

VI.5) Date of dispatch of this notice

28/06/2019

Coding

Commodity categories

ID Title Parent category
33124000 Diagnostics and radiodiagnostic devices and supplies Recording systems and exploration devices
33100000 Medical equipments Medical equipments, pharmaceuticals and personal care products

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
alan.summers@nhs.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.